60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SXTP 60 degrees pharmaceuticals, Inc.

Not Yet Opened 09-09 16:00:00 EDT

0.9402

-0.0366

-3.75%

盘后0.9402

+0.00000.00%

19:30 EDT

High0.9995	Low0.9300	Vol30.61K
Open0.9800	D1 Closing0.9768	Amplitude7.12%
Mkt Cap3.31M	Tradable Cap1.67M	Total Shares3.52M
T/O29.26K	T/O Rate1.73%	Tradable Shares1.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":0.9402,"timestamp":1788984000000,"preClose":0.9768,"halted":0,"volume":30607,"hourTrading":{"tag":"盘后","latestPrice":0.9402,"preClose":0.9402,"latestTime":"19:30 EDT","volume":8,"amount":7.5216,"timestamp":1788996606979,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03746928746928743,"floatShares":1772000,"shares":3517000,"eps":-6.3166,"marketStatus":"Not Yet Opened","change":-0.0366,"latestTime":"09-09 16:00:00 EDT","open":0.98,"high":0.9995,"low":0.93,"amount":29257.9566859,"amplitude":0.071151,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.3166,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789027200000},"marketStatusCode":0,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":0.9768,"preHourTrading":{"tag":"盘前","latestPrice":0.9328,"preClose":0.9768,"latestTime":"08:22 EDT","volume":3688,"amount":3618.4668168000003,"timestamp":1788956541844,"change":-0.044,"changeRate":-0.045045,"amplitude":0.079034},"postHourTrading":{"tag":"盘后","latestPrice":0.9402,"preClose":0.9402,"latestTime":"19:30 EDT","volume":8,"amount":7.5216,"timestamp":1788996606979,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.444692},"requestUrl":"/m/hq/s/SXTP/tweets","defaultTab":"tweets","newsList":[{"id":"2666737097","title":"60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2666737097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666737097?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:07","pubTimestamp":1788901664,"startTime":"0","endTime":"0","summary":"The latest update is out from 60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ). On September 8, 2026, 60 Degrees Pharmaceuticals updated its investor p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-updates-strategy-for-tick-borne-diseases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-updates-strategy-for-tick-borne-diseases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","PRTO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877975","title":"60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877975","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877975?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:04","pubTimestamp":1788437040,"startTime":"0","endTime":"0","summary":"– On-demand company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET – – Management will be available for one-on-one investor meetings during the conference – WASHINGTON, S","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355877/0/en/60-degrees-pharmaceuticals-announces-participation-in-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRTO","BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436400","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436400","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436400?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:30","pubTimestamp":1786980619,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-omniab-oabi-bicycle-therapeutics-bcyc-and-60-degrees-pharmaceuticals-inc-sxtp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-omniab-oabi-bicycle-therapeutics-bcyc-and-60-degrees-pharmaceuticals-inc-sxtp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4007","BK4137","PRTO","XBI","LU0128526141.USD","BK4121","BK4585","BK4588","LU0029874061.USD","OABI","HCSG","SXTP","BK4581","BCYC","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126952","title":"60 Degrees Pharmaceuticals Q2 EPS USD -0.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126952?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:47","pubTimestamp":1786736826,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLXQMW564:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112695","title":"60 Degrees Pharmaceuticals Q2 Operating Expenses USD 2.33 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112695","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112695?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:47","pubTimestamp":1786736826,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLXQMW564:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659612699","title":"Press Release: 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659612699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659612699?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:47","pubTimestamp":1786736820,"startTime":"0","endTime":"0","summary":"WASHINGTON, Aug. 14, 2026  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for vector-borne diseases, reported today its financial results for the second quarter of 2026, ended June 30, 2026.Financial Highlights for the Quarter Ended June 30, 2026:-- Net product revenues increased approximately 106% to approximately $208. thousand for the second quarter of 2026, from approximately $101 thousand. -- Gross profit on product revenues was approximately $57 thousand for the. second quarter of 2026, compared with approximately $51 thousand for the. -- Operating expenses were approximately $2.33 million for the second. quarter of 2026, compared with approximately $1.86 million for the second. -- Net loss attributable to common stockholders was approximately $2.40. million, or $0.90 per share, for the second quarter of 2026, compared. with a net loss of approximately $1.84 million, or $5.01 per share, for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","PRTO","BK4022","R","BK4007","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659266921","title":"60 Degrees Pharma Q2 FY26 Net Loss Widens 30.6% to $2.26 Million; Revenue More than Doubles to $207,898","url":"https://stock-news.laohu8.com/highlight/detail?id=2659266921","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659266921?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:35","pubTimestamp":1786736156,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma Q2 FY26 net loss widens 30.6% to $2.26 million; revenue more than doubles to $207,89860 Degrees Pharmaceuticals posted a net loss attributable to shareholders of $2.26 million for Q2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL8y94fd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666398","title":"60 Degrees Pharmaceuticals Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666398","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666398?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:50","pubTimestamp":1786049406,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals holds annual shareholder meeting60 Degrees Pharmaceuticals held its 2026 annual stockholders meeting on Aug. 5, 2026.Shareholders backed the selection of five directors, wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL6mqzyf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657377560","title":"60 Degrees Pharmaceuticals Issues Series A, Series B Warrants Exercisable at $1.49 in $1 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657377560","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657377560?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:39","pubTimestamp":1785879562,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement60 Degrees Pharmaceuticals priced a private placement at $1.74 per share with series A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL9WWN3q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560505","title":"60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560505?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:30","pubTimestamp":1785879009,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) just unveiled an update. On July 30, 2026, 60 Degrees Pharmaceuticals entered into definitive securiti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-completes-private-placement-to-raise-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-completes-private-placement-to-raise-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP","PRTO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655780013","title":"60 Degrees Pharmaceuticals to sell shares and warrants in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2655780013","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655780013?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:35","pubTimestamp":1785436543,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 574,713 sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-to-sell-shares-and-warrants-in-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-to-sell-shares-and-warrants-in-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRTO","SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800802","title":"60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced at-the-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800802?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:23","pubTimestamp":1785435780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nTUA2YRRWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTPW","BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655819873","title":"60 Degrees Pharma Hits Minimum Enrollment Trigger for Interim Readout in Severe Babesiosis Tafenoquine Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2655819873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655819873?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:16","pubTimestamp":1785356217,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma hits minimum enrollment trigger for interim readout in severe babesiosis tafenoquine trial60 Degrees Pharmaceuticals reached the minimum 24-patient enrollment for an interim analysis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL4jkZ8n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816359","title":"60 Degrees Pharmaceuticals Files Form 3 Showing Knight Therapeutics Stake of 658,629 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816359","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816359?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:07","pubTimestamp":1785355636,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals files Form 3 showing Knight Therapeutics stake of 658,629 sharesKnight Therapeutics filed a Form 3 showing it holds 658,629 shares of 60 Degrees Pharmaceuticals common stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL7g1TRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655815445","title":"60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655815445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655815445?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:03","pubTimestamp":1785355380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA1BG9RH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTPW","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655811465","title":"60 Degrees Pharmaceuticals - Company to Request FDA Meeting on Nda Pathway for Tafenoquine in Babesiosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655811465?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:03","pubTimestamp":1785355380,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA1BG9RH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653524633","title":"60 Degrees updates strategy for ARAKODA and profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2653524633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653524633?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:34","pubTimestamp":1784579675,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) just unveiled an announcement. On July 20, 2026, 60 Degrees Pharmaceuticals updated its investor prese...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-updates-strategy-for-arakoda-and-profitability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-updates-strategy-for-arakoda-and-profitability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649937959","title":"60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-borne Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2649937959","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649937959?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:01","pubTimestamp":1783512060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nTUAGDGMD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTPW","SXTP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648454821","title":"60 Degrees Pharma Says DSMB Backs Continuing Phase 2 Tafenoquine Chronic Babesiosis Fatigue Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2648454821","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648454821?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:21","pubTimestamp":1782908462,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma says DSMB backs continuing Phase 2 tafenoquine chronic babesiosis fatigue study60 Degrees Pharma said its independent Data Safety Monitoring Board recommended continuing the B-FREE P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL6l4mqs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648488645","title":"60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-free Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue","url":"https://stock-news.laohu8.com/highlight/detail?id=2648488645","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648488645?lang=en_us&edition=fundamental","pubTime":"2026-07-01 20:02","pubTimestamp":1782907320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUA1YQ18G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTP","SXTPW"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.60degreespharma.com","stockEarnings":[{"period":"1week","weight":-0.0424},{"period":"1month","weight":-0.1279},{"period":"3month","weight":-0.2922},{"period":"6month","weight":-0.6643},{"period":"1year","weight":-0.8243},{"period":"ytd","weight":-0.5196}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.0094},{"period":"3month","weight":0.0559},{"period":"6month","weight":0.15},{"period":"1year","weight":0.1805},{"period":"ytd","weight":0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.040319},{"month":2,"riseRate":0,"avgChangeRate":-0.262735},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.15171},{"month":4,"riseRate":0.333333,"avgChangeRate":0.079946},{"month":5,"riseRate":0.333333,"avgChangeRate":0.058798},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.011364},{"month":7,"riseRate":0,"avgChangeRate":-0.39553},{"month":8,"riseRate":0.25,"avgChangeRate":-0.160667},{"month":9,"riseRate":0.25,"avgChangeRate":-0.146117},{"month":10,"riseRate":0,"avgChangeRate":-0.229986},{"month":11,"riseRate":0.666667,"avgChangeRate":0.078807},{"month":12,"riseRate":0.666667,"avgChangeRate":0.11386}],"exchange":"NASDAQ","name":"60 degrees pharmaceuticals, Inc.","nameEN":"60 degrees pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 60 degrees pharmaceuticals, Inc.(SXTP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"60 degrees pharmaceuticals, Inc.,SXTP,60 degrees pharmaceuticals, Inc.股票,60 degrees pharmaceuticals, Inc.股票老虎,60 degrees pharmaceuticals, Inc.股票老虎国际,60 degrees pharmaceuticals, Inc.行情,60 degrees pharmaceuticals, Inc.股票行情,60 degrees pharmaceuticals, Inc.股价,60 degrees pharmaceuticals, Inc.股市,60 degrees pharmaceuticals, Inc.股票价格,60 degrees pharmaceuticals, Inc.股票交易,60 degrees pharmaceuticals, Inc.股票购买,60 degrees pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 60 degrees pharmaceuticals, Inc.(SXTP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction